JID innovations : skin science from molecules to population health最新文献

筛选
英文 中文
An integrative epidermal epigenome-transcriptome reference for cytokine regulation 细胞因子调控的综合表皮表观基因组-转录组参考。
JID innovations : skin science from molecules to population health Pub Date : 2026-11-01 Epub Date: 2026-10-06 DOI: 10.1016/j.xjidi.2026.100550
Shenghua Tian, Bingjie Li, Tao Huang, Sijia Wang
{"title":"An integrative epidermal epigenome-transcriptome reference for cytokine regulation","authors":"Shenghua Tian, Bingjie Li, Tao Huang, Sijia Wang","doi":"10.1016/j.xjidi.2026.100550","DOIUrl":"10.1016/j.xjidi.2026.100550","url":null,"abstract":"<div><div>Cytokines serve as pathogenic drivers and therapeutic targets in inflammatory and autoimmune skin diseases. While blood-based cytokine studies have highlighted the importance of genetic and epigenetic regulation, they fail to capture the tissue heterogeneity of skin diseases. To characterize the epigenetic regulation of skin cytokines, we collected and analyzed matched epidermal DNA methylome, transcriptome, and cytokine profiles of 120 healthy individuals, establishing a reference resource that can be applied to external skin disease and treatment datasets. Our analysis identified 4187 differentially methylated probes and 461 differentially methylated and expressed genes associated with skin cytokines, revealing tissue-specific patterns of epigenetic regulation. Using the RNA expression and DNA methylation levels of these differentially methylated and expressed genes, we developed omics risk scores for each cytokine. Notably, transcriptomic scores for 6 cytokines showed relatively higher predictive performance in the discovery cohort (R<sup>2</sup> range: 30–58%) and showed disease-associated differences when applied to external public datasets. In addition, we developed CytoEpi (<span><span>https://cytoepi.shinyapps.io/cytoepi/</span><svg><path></path></svg></span>), a web application for broader community access and exploration of these cytokine regulatory insights. Overall, this study establishes a foundational multi-omics reference resource on cytokine regulation in healthy skin and provides a useful resource to advance future research into the mechanisms and treatment of inflammatory skin diseases.</div></div><div>Cytokines serve as pathogenic drivers and therapeutic targets in inflammatory and autoimmune skin diseases. While blood-based cytokine studies have highlighted the importance of genetic and epigenetic regulation, they fail to capture the tissue heterogeneity of skin diseases. To characterize the epigenetic regulation of skin cytokines, we collected and analyzed matched epidermal DNA methylome, transcriptome, and cytokine profiles of 120 healthy individuals, establishing a reference resource that can be applied to external skin disease and treatment datasets. Our analysis identified 4187 differentially methylated probes and 461 differentially methylated and expressed genes associated with skin cytokines, revealing tissue-specific patterns of epigenetic regulation. Using the RNA expression and DNA methylation levels of these differentially methylated and expressed genes, we developed omics risk scores for each cytokine. Notably, transcriptomic scores for 6 cytokines showed relatively higher predictive performance in the discovery cohort (R<sup>2</sup> range: 30–58%) and showed disease-associated differences when applied to external public datasets. In addition, we developed CytoEpi (<span><span>https://cytoepi.shinyapps.io/cytoepi/</span><svg><path></path></svg></span>), a web application for broader community access and e","PeriodicalId":73548,"journal":{"name":"JID innovations : skin science from molecules to population health","volume":"6 6","pages":"Article 100550"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13735250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149344961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leishmania braziliensis infection enhances adipokine and cytokine production and severity of cutaneous leishmaniasis in patients with obesity 巴西利什曼原虫感染增加肥胖患者皮肤利什曼病的脂肪因子和细胞因子的产生和严重程度
JID innovations : skin science from molecules to population health Pub Date : 2026-11-01 Epub Date: 2026-09-24 DOI: 10.1016/j.xjidi.2026.100543
Kelly Morais Lima Nassri, Augusto M. Carvalho, Tainã S. Lago, Maurício T. Nascimento, Carla Silva Dias, Jamile S. Lago, Paulo R.L. Machado, Alexsandro S. Lago, Andréa Santos Magalhães, Sérgio Marcos Arruda, Lucas P. Carvalho, Edgar M. Carvalho
{"title":"Leishmania braziliensis infection enhances adipokine and cytokine production and severity of cutaneous leishmaniasis in patients with obesity","authors":"Kelly Morais Lima Nassri,&nbsp;Augusto M. Carvalho,&nbsp;Tainã S. Lago,&nbsp;Maurício T. Nascimento,&nbsp;Carla Silva Dias,&nbsp;Jamile S. Lago,&nbsp;Paulo R.L. Machado,&nbsp;Alexsandro S. Lago,&nbsp;Andréa Santos Magalhães,&nbsp;Sérgio Marcos Arruda,&nbsp;Lucas P. Carvalho,&nbsp;Edgar M. Carvalho","doi":"10.1016/j.xjidi.2026.100543","DOIUrl":"10.1016/j.xjidi.2026.100543","url":null,"abstract":"<div><div>Cutaneous leishmaniasis (CL) is more severe in obese individuals than in lean individuals. Here, we investigated the contribution of adipose tissue to the severity of CL in 39 obese and 43 lean patients with CL, along with 8 healthy subjects. Skin and subcutaneous biopsies were evaluated by histopathology and cytokine/adipokine analysis. Obese patients showed a lower response rate to antimony therapy (41% vs 70.4%) and longer healing times (P &lt; .05). Histopathological analysis revealed denser dermal and subcutaneous inflammatory infiltrates in obese patients, which were predominantly composed of macrophages and lymphocytes, associated with high adipose tissue production of CCL-2. Obese patients exhibited increased dermal expression of TNF, IL-1β, IL-17, and granzyme B, all markers associated with disease severity. Leptin levels correlated positively with these inflammatory mediators, and leptin neutralization reduced their production. Leishmania infection also altered adipokine profiles: adiponectin levels were 10.5-fold higher in lean patients with CL than in lean healthy subjects, while leptin levels were 3.1-fold higher in obese patients with CL than in obese healthy subjects (P &lt; .05). These findings indicate that in Leishmania braziliensis infection, adipocytes and dermal cells drive inflammatory cell infiltration into both subcutaneous and dermal compartments, accompanied by marked adipokine and cytokine production that amplifies tissue pathology.</div></div><div>Cutaneous leishmaniasis (CL) is more severe in obese individuals than in lean individuals. Here, we investigated the contribution of adipose tissue to the severity of CL in 39 obese and 43 lean patients with CL, along with 8 healthy subjects. Skin and subcutaneous biopsies were evaluated by histopathology and cytokine/adipokine analysis. Obese patients showed a lower response rate to antimony therapy (41% vs 70.4%) and longer healing times (P &lt; .05). Histopathological analysis revealed denser dermal and subcutaneous inflammatory infiltrates in obese patients, which were predominantly composed of macrophages and lymphocytes, associated with high adipose tissue production of CCL-2. Obese patients exhibited increased dermal expression of TNF, IL-1β, IL-17, and granzyme B, all markers associated with disease severity. Leptin levels correlated positively with these inflammatory mediators, and leptin neutralization reduced their production. Leishmania infection also altered adipokine profiles: adiponectin levels were 10.5-fold higher in lean patients with CL than in lean healthy subjects, while leptin levels were 3.1-fold higher in obese patients with CL than in obese healthy subjects (P &lt; .05). These findings indicate that in Leishmania braziliensis infection, adipocytes and dermal cells drive inflammatory cell infiltration into both subcutaneous and dermal compartments, accompanied by marked adipokine and cytokine production that amplifies tissue pathology.</div>","PeriodicalId":73548,"journal":{"name":"JID innovations : skin science from molecules to population health","volume":"6 6","pages":"Article 100543"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149354331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
De novo regeneration of rete ridges during cetacean skin wound healing 鲸类动物皮肤创面愈合过程中网状嵴的新生。
JID innovations : skin science from molecules to population health Pub Date : 2026-11-01 Epub Date: 2026-09-21 DOI: 10.1016/j.xjidi.2026.100540
Tzu-Yu Liu, Hao-Ven Wang, Wei-Cheng Yang, Chao-Chun Yang, Chen-Yi Su, Yun-Ting Chiou, Tsyr-Huei Chiou, Shyh-Jou Shieh, Ming-Jer Tang, Cheng-Ming Chuong, Michael W. Hughes
{"title":"De novo regeneration of rete ridges during cetacean skin wound healing","authors":"Tzu-Yu Liu,&nbsp;Hao-Ven Wang,&nbsp;Wei-Cheng Yang,&nbsp;Chao-Chun Yang,&nbsp;Chen-Yi Su,&nbsp;Yun-Ting Chiou,&nbsp;Tsyr-Huei Chiou,&nbsp;Shyh-Jou Shieh,&nbsp;Ming-Jer Tang,&nbsp;Cheng-Ming Chuong,&nbsp;Michael W. Hughes","doi":"10.1016/j.xjidi.2026.100540","DOIUrl":"10.1016/j.xjidi.2026.100540","url":null,"abstract":"&lt;div&gt;&lt;div&gt;Tight-skinned mammals develop skin that is adhered to underlying tissues, limiting independent movement. Humans, being tight-skinned, fail to regenerate large full-thickness wounds and instead scar with concomitant loss of function. Mechanical context strongly influences outcomes, as increased tissue tension and stiffness promote fibrotic repair, including hypertrophic and keloid scarring. Consequently, regenerative medicine research has relied on animal models to investigate the balance between scarring and regeneration. Loose-skinned mammals, including laboratory mice, exhibit a greater regenerative capacity via lower-stiffness skin, and are modulated toward regenerative or fibrotic trajectories. Despite progress, normal skin architecture restoration after large full-thickness injury is not elucidated in tight-skinned mammals. To address whether tight-skinned mammals can regenerate with minimal scarring, cookie-cutter shark (&lt;em&gt;Isistius sp.&lt;/em&gt;)-induced wounds were collected from Fraser’s dolphins. Tight-skinned Fraser’s dolphins regenerate complex rete ridge architecture de novo with associated vasculature and minimal scarring following large full-thickness injury. These complex rete ridges contain branches that are intimately associated with vasculature. During healing, the migrating epithelial tongue exhibits small protrusions that develop into mature rete ridges. Regeneration proceeds sequentially; initially, rete ridges form, then vascularization, and later branching morphogenesis. Counterintuitively, skin regeneration occurs in an aqueous, high-shear stress, and high-tension environment. These findings identify a unique mammalian ability to rebuild elaborate architecture under mechanically restrictive conditions.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;Tight-skinned mammals develop skin that is adhered to underlying tissues, limiting independent movement. Humans, being tight-skinned, fail to regenerate large full-thickness wounds and instead scar with concomitant loss of function. Mechanical context strongly influences outcomes, as increased tissue tension and stiffness promote fibrotic repair, including hypertrophic and keloid scarring. Consequently, regenerative medicine research has relied on animal models to investigate the balance between scarring and regeneration. Loose-skinned mammals, including laboratory mice, exhibit a greater regenerative capacity via lower-stiffness skin, and are modulated toward regenerative or fibrotic trajectories. Despite progress, normal skin architecture restoration after large full-thickness injury is not elucidated in tight-skinned mammals. To address whether tight-skinned mammals can regenerate with minimal scarring, cookie-cutter shark (&lt;em&gt;Isistius sp.&lt;/em&gt;)-induced wounds were collected from Fraser’s dolphins. Tight-skinned Fraser’s dolphins regenerate complex rete ridge architecture de novo with associated vasculature and minimal scarring following large full-thickness injury. These complex rete ridges contai","PeriodicalId":73548,"journal":{"name":"JID innovations : skin science from molecules to population health","volume":"6 6","pages":"Article 100540"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13738183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149344962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A simple and minimally invasive device for skin sampling and molecular detection in cutaneous fungal infections 一种用于皮肤真菌感染的皮肤采样和分子检测的简单微创装置。
JID innovations : skin science from molecules to population health Pub Date : 2026-11-01 Epub Date: 2026-09-26 DOI: 10.1016/j.xjidi.2026.100545
Kun Liang, Larissa Lim, Amelia Yuting Monteiro, Hui Mei Cheng, Jia Min Loh, Thomas Larry Dawson Jr., Cheryl Leong, Hong Liang Tey
{"title":"A simple and minimally invasive device for skin sampling and molecular detection in cutaneous fungal infections","authors":"Kun Liang,&nbsp;Larissa Lim,&nbsp;Amelia Yuting Monteiro,&nbsp;Hui Mei Cheng,&nbsp;Jia Min Loh,&nbsp;Thomas Larry Dawson Jr.,&nbsp;Cheryl Leong,&nbsp;Hong Liang Tey","doi":"10.1016/j.xjidi.2026.100545","DOIUrl":"10.1016/j.xjidi.2026.100545","url":null,"abstract":"&lt;div&gt;&lt;div&gt;Skin fungal infections present a significant global disease burden worldwide and are difficult to treat owing to their frequent recurrence. To date, we have witnessed significant advancements in the fungi detection using molecular methods, yet little attention has been given to the standard clinical practice of sample collection through skin scraping, which is operator and skill dependent and only limited to the surface. In this study, we evaluated the clinical utility of a previously reported sampling tool—microprojection array—as a minimally invasive sampling approach for molecular detection of fungi in patients with suspected skin infections. Skin samples collected using scrapes were similarly processed in comparison. Detection using pan-fungal qPCR enabled differentiation between samples infected with &lt;em&gt;Trichophyton&lt;/em&gt; and those infected with &lt;em&gt;Candida&lt;/em&gt;, whereas metagenomic sequencing analysis provided more detailed species-level identification—particularly for &lt;em&gt;C albicans&lt;/em&gt;—and demonstrated greater sensitivity than microscopy and culture. Among clinically positive samples, both sampling methods showed comparable relative abundance profiles. Nevertheless, we observed variations in the detection of certain species between the 2 sampling approaches, which suggests possible differences in the spatial distribution of these fungi. Overall, the findings demonstrated the feasibility of combining microprojection array–based transepidermal sampling with established molecular detection methods to facilitate clinical fungal diagnosis.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;Skin fungal infections present a significant global disease burden worldwide and are difficult to treat owing to their frequent recurrence. To date, we have witnessed significant advancements in the fungi detection using molecular methods, yet little attention has been given to the standard clinical practice of sample collection through skin scraping, which is operator and skill dependent and only limited to the surface. In this study, we evaluated the clinical utility of a previously reported sampling tool—microprojection array—as a minimally invasive sampling approach for molecular detection of fungi in patients with suspected skin infections. Skin samples collected using scrapes were similarly processed in comparison. Detection using pan-fungal qPCR enabled differentiation between samples infected with &lt;em&gt;Trichophyton&lt;/em&gt; and those infected with &lt;em&gt;Candida&lt;/em&gt;, whereas metagenomic sequencing analysis provided more detailed species-level identification—particularly for &lt;em&gt;C albicans&lt;/em&gt;—and demonstrated greater sensitivity than microscopy and culture. Among clinically positive samples, both sampling methods showed comparable relative abundance profiles. Nevertheless, we observed variations in the detection of certain species between the 2 sampling approaches, which suggests possible differences in the spatial distribution of these fungi. Overall, the findings demonstrated t","PeriodicalId":73548,"journal":{"name":"JID innovations : skin science from molecules to population health","volume":"6 6","pages":"Article 100545"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13735249/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149344900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporal outcomes and biomarkers of rituximab treatment response in pemphigus: Validation of a historical control dataset 天疱疮利妥昔单抗治疗反应的时间结果和生物标志物:历史对照数据集的验证
JID innovations : skin science from molecules to population health Pub Date : 2026-09-01 Epub Date: 2026-07-20 DOI: 10.1016/j.xjidi.2026.100510
Chuda Rujitharanawong, Sasima Tongsai, Aimee S. Payne
{"title":"Temporal outcomes and biomarkers of rituximab treatment response in pemphigus: Validation of a historical control dataset","authors":"Chuda Rujitharanawong,&nbsp;Sasima Tongsai,&nbsp;Aimee S. Payne","doi":"10.1016/j.xjidi.2026.100510","DOIUrl":"10.1016/j.xjidi.2026.100510","url":null,"abstract":"&lt;div&gt;&lt;div&gt;Rituximab and corticosteroids remain the only clinically approved therapies for pemphigus vulgaris, although novel therapeutics are entering clinical development. A historical control dataset previously described clinical and serologic outcomes after rituximab therapy in pemphigus vulgaris, but whether these data are representative of other patient cohorts is currently unclear. A contemporary pemphigus vulgaris cohort (n = 97) was compared with the historical cohort (n = 107) to assess clinical outcomes as well as desmoglein 3 ELISA predictive performance for achieving complete remission off oral immunosuppressive therapy. A total of 41.2% of patients achieved complete remission off oral immunosuppressive therapy after the first rituximab cycle, with a maximum complete remission off oral immunosuppressive therapy prevalence of 52.8% at month 36, including multiple rituximab cycles. Despite differences in baseline characteristics and treatments (particularly rituximab dosing), the temporal patterns of remission, relapse, and retreatment were broadly similar across cohorts. A desmoglein 3 ELISA index value ≤ 130 RU/ml and &gt; 90.7% titer reduction between months 3 and 9 demonstrated 90% specificity and 88% sensitivity for future achievement of complete remission off oral immunosuppressive therapy, with negative predictive values of 85% and 92%, respectively, suggesting that low and/or rapid large drops in autoantibody titers after rituximab may predict an absence of disease activity. These data describe the temporal outcomes of rituximab therapy in pemphigus vulgaris and validate the historical control dataset for future comparative effectiveness research and biomarker-driven management.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;Rituximab and corticosteroids remain the only clinically approved therapies for pemphigus vulgaris, although novel therapeutics are entering clinical development. A historical control dataset previously described clinical and serologic outcomes after rituximab therapy in pemphigus vulgaris, but whether these data are representative of other patient cohorts is currently unclear. A contemporary pemphigus vulgaris cohort (n = 97) was compared with the historical cohort (n = 107) to assess clinical outcomes as well as desmoglein 3 ELISA predictive performance for achieving complete remission off oral immunosuppressive therapy. A total of 41.2% of patients achieved complete remission off oral immunosuppressive therapy after the first rituximab cycle, with a maximum complete remission off oral immunosuppressive therapy prevalence of 52.8% at month 36, including multiple rituximab cycles. Despite differences in baseline characteristics and treatments (particularly rituximab dosing), the temporal patterns of remission, relapse, and retreatment were broadly similar across cohorts. A desmoglein 3 ELISA index value ≤ 130 RU/ml and &gt; 90.7% titer reduction between months 3 and 9 demonstrated 90% specificity and 88% sensitivity for future achievemen","PeriodicalId":73548,"journal":{"name":"JID innovations : skin science from molecules to population health","volume":"6 5","pages":"Article 100510"},"PeriodicalIF":0.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149051164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cover 封面
JID innovations : skin science from molecules to population health Pub Date : 2026-09-01 Epub Date: 2026-09-24 DOI: 10.1016/S2667-0267(26)00092-5
{"title":"Cover","authors":"","doi":"10.1016/S2667-0267(26)00092-5","DOIUrl":"10.1016/S2667-0267(26)00092-5","url":null,"abstract":"","PeriodicalId":73548,"journal":{"name":"JID innovations : skin science from molecules to population health","volume":"6 5","pages":"Article 100537"},"PeriodicalIF":0.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149051162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complete remission after rituximab therapy of pemphigus: Real-world evidence on dosing regimens and retreatment strategies 利妥昔单抗治疗天疱疮后完全缓解:剂量方案和再治疗策略的真实世界证据
JID innovations : skin science from molecules to population health Pub Date : 2026-09-01 Epub Date: 2026-08-06 DOI: 10.1016/j.xjidi.2026.100508
Chuda Rujitharanawong, Sasima Tongsai, Aimee S. Payne
{"title":"Complete remission after rituximab therapy of pemphigus: Real-world evidence on dosing regimens and retreatment strategies","authors":"Chuda Rujitharanawong,&nbsp;Sasima Tongsai,&nbsp;Aimee S. Payne","doi":"10.1016/j.xjidi.2026.100508","DOIUrl":"10.1016/j.xjidi.2026.100508","url":null,"abstract":"<div><div>Although rituximab is clinically approved for pemphigus, real-world data on predictors of treatment success and optimal dosing remain limited. We conducted a retrospective cohort study of patients with pemphigus treated with rituximab with ≥1 year of follow-up at NewYork-Presbyterian Hospital. Patients initially received two 1000 mg doses 2 weeks apart or 4 weekly weight-adjusted (375 mg/m<sup>2</sup>) infusions. Factors associated with complete remission (CR) off oral immunosuppressive therapy were analyzed using Kaplan–Meier and Cox proportional hazards analyses. Among 105 patients, 44.7% achieved CR off therapy after the first rituximab cycle, increasing to 74.3% after multiple cycles, with a median time to remission of 7.4 months. Weight-adjusted rituximab dosing was associated with a higher likelihood of achieving CR off oral immunosuppressive therapy after the first rituximab cycle than the fixed-dose regimen (hazard ratio = 2.49, <em>P</em> = .01). For subsequent treatment, maintenance rituximab infusions every 6 months were associated with a shorter time to initial achievement of CR off therapy and a longer time to relapse than an on-demand approach; however, both achieved similar overall rates of CR off therapy. These findings support the benefit of weight-adjusted dosing for the first rituximab cycle and provide real-world data on outcomes of maintenance versus on-demand rituximab infusions for pemphigus therapy.</div></div><div>Although rituximab is clinically approved for pemphigus, real-world data on predictors of treatment success and optimal dosing remain limited. We conducted a retrospective cohort study of patients with pemphigus treated with rituximab with ≥1 year of follow-up at NewYork-Presbyterian Hospital. Patients initially received two 1000 mg doses 2 weeks apart or 4 weekly weight-adjusted (375 mg/m<sup>2</sup>) infusions. Factors associated with complete remission (CR) off oral immunosuppressive therapy were analyzed using Kaplan–Meier and Cox proportional hazards analyses. Among 105 patients, 44.7% achieved CR off therapy after the first rituximab cycle, increasing to 74.3% after multiple cycles, with a median time to remission of 7.4 months. Weight-adjusted rituximab dosing was associated with a higher likelihood of achieving CR off oral immunosuppressive therapy after the first rituximab cycle than the fixed-dose regimen (hazard ratio = 2.49, <em>P</em> = .01). For subsequent treatment, maintenance rituximab infusions every 6 months were associated with a shorter time to initial achievement of CR off therapy and a longer time to relapse than an on-demand approach; however, both achieved similar overall rates of CR off therapy. These findings support the benefit of weight-adjusted dosing for the first rituximab cycle and provide real-world data on outcomes of maintenance versus on-demand rituximab infusions for pemphigus therapy.</div>","PeriodicalId":73548,"journal":{"name":"JID innovations : skin science from molecules to population health","volume":"6 5","pages":"Article 100508"},"PeriodicalIF":0.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149051163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imaging transcriptomics in basal cell carcinoma: Coupling in vivo tumor morphology with gene expression 基底细胞癌的成像转录组学:体内肿瘤形态与基因表达的耦合
JID innovations : skin science from molecules to population health Pub Date : 2026-09-01 Epub Date: 2026-07-28 DOI: 10.1016/j.xjidi.2026.100519
Kevin Jacobsen, Olivia Luxford Meyer, Stine Bøttcher Jacobsen, Vinzent Kevin Ortner, Silje Haukali Omland, Katrine Elisabeth Karmisholt, Martin Glud, Stine Regin Wiegell, Aditi Sahu, Cyril Maliakal, Niels Morling, Peter Alshede Philipsen, Jeppe Dyrberg Andersen, Merete Haedersdal
{"title":"Imaging transcriptomics in basal cell carcinoma: Coupling in vivo tumor morphology with gene expression","authors":"Kevin Jacobsen,&nbsp;Olivia Luxford Meyer,&nbsp;Stine Bøttcher Jacobsen,&nbsp;Vinzent Kevin Ortner,&nbsp;Silje Haukali Omland,&nbsp;Katrine Elisabeth Karmisholt,&nbsp;Martin Glud,&nbsp;Stine Regin Wiegell,&nbsp;Aditi Sahu,&nbsp;Cyril Maliakal,&nbsp;Niels Morling,&nbsp;Peter Alshede Philipsen,&nbsp;Jeppe Dyrberg Andersen,&nbsp;Merete Haedersdal","doi":"10.1016/j.xjidi.2026.100519","DOIUrl":"10.1016/j.xjidi.2026.100519","url":null,"abstract":"&lt;div&gt;&lt;div&gt;Combining spatial and molecular information enhances understanding of skin cancer biology. In this exploratory study, we investigated such associations in basal cell carcinoma (BCC) using 2 non-invasive approaches: line-field confocal optical coherence tomography (LC-OCT) to assess tumor morphology and tape stripping for gene expression profiling. With development, this combined image-transcriptomic approach could contribute to understanding of BCC pathogenesis in vivo. Histology-confirmed BCCs (n = 53) and control skin were scanned with LC-OCT for 44 morphological features and sampled via tape stripping for mRNA analysis. Differentially expressed genes were identified and examined through pathway-enrichment to uncover mechanisms. Seven LC-OCT image-features were associated with BCC compared with control skin (&lt;em&gt;P&lt;/em&gt; ≤ .004). Seventy-two differentially expressed genes were identified in BCC (false discovery rate &lt;0.001). A subset of 27 differentially expressed genes correlated with 2 LC-OCT features—the millefeuille pattern and collagen alterations—showing a 3.9 - to 11.8-fold increase in gene expression levels. Pathway-enrichment analysis highlighted BCL2A1, linked to tumorigenesis, in association with the millefeuille pattern, and FMO2, involved in collagen synthesis, with collagen alterations. This imaging–transcriptomic approach confirms the feasibility of tape stripping for detecting BCC-specific gene expression and introduces LC-OCT-based imaging transcriptomics, for investigating BCC pathobiology in vivo.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;Combining spatial and molecular information enhances understanding of skin cancer biology. In this exploratory study, we investigated such associations in basal cell carcinoma (BCC) using 2 non-invasive approaches: line-field confocal optical coherence tomography (LC-OCT) to assess tumor morphology and tape stripping for gene expression profiling. With development, this combined image-transcriptomic approach could contribute to understanding of BCC pathogenesis in vivo. Histology-confirmed BCCs (n = 53) and control skin were scanned with LC-OCT for 44 morphological features and sampled via tape stripping for mRNA analysis. Differentially expressed genes were identified and examined through pathway-enrichment to uncover mechanisms. Seven LC-OCT image-features were associated with BCC compared with control skin (&lt;em&gt;P&lt;/em&gt; ≤ .004). Seventy-two differentially expressed genes were identified in BCC (false discovery rate &lt;0.001). A subset of 27 differentially expressed genes correlated with 2 LC-OCT features—the millefeuille pattern and collagen alterations—showing a 3.9 - to 11.8-fold increase in gene expression levels. Pathway-enrichment analysis highlighted BCL2A1, linked to tumorigenesis, in association with the millefeuille pattern, and FMO2, involved in collagen synthesis, with collagen alterations. This imaging–transcriptomic approach confirms the feasibility of tape stripping for detecting BCC-specif","PeriodicalId":73548,"journal":{"name":"JID innovations : skin science from molecules to population health","volume":"6 5","pages":"Article 100519"},"PeriodicalIF":0.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148951064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demographic factors associated with skin barrier function in a large population-based study 在一项基于人群的大型研究中,人口统计学因素与皮肤屏障功能相关
JID innovations : skin science from molecules to population health Pub Date : 2026-07-01 Epub Date: 2026-04-29 DOI: 10.1016/j.xjidi.2026.100480
Katrina Abuabara, Benjamin Stroebel, Shreya Sreekantaswamy, Richard W. Kim, Linda Zukley, Noreen Karim, Robert H. Rice, Blythe P. Durbin-Johnson, David M. Rocke, Theodora Mauro
{"title":"Demographic factors associated with skin barrier function in a large population-based study","authors":"Katrina Abuabara,&nbsp;Benjamin Stroebel,&nbsp;Shreya Sreekantaswamy,&nbsp;Richard W. Kim,&nbsp;Linda Zukley,&nbsp;Noreen Karim,&nbsp;Robert H. Rice,&nbsp;Blythe P. Durbin-Johnson,&nbsp;David M. Rocke,&nbsp;Theodora Mauro","doi":"10.1016/j.xjidi.2026.100480","DOIUrl":"10.1016/j.xjidi.2026.100480","url":null,"abstract":"<div><div>The skin plays a vital role in homeostasis, but there are conflicting data on skin barrier function–associated factors. We evaluated the relationship between participant characteristics and barrier function measures (baseline transepidermal water loss, barrier integrity [number of tape strips required to increase transepidermal water loss by 4 times baseline], dynamic barrier function [area under the curve of number of tape strips plotted against repeated transepidermal water loss measurements], and barrier recovery [percentage recovery in transepidermal water loss 24 hours after tape stripping]) in 286 participants aged 32–97 years in the Baltimore Longitudinal Study of Aging cohort. Multivariable analysis indicated that older age, female sex, Black race, and higher body mass index were associated with at least 1 measure of better barrier function: older age was associated with better dynamic barrier function (beta = −0.071, <em>P</em> = .035) and baseline barrier permeability (beta = −0.045, <em>P</em> = .018), female participants had better dynamic barrier function (beta = −2.028, <em>P</em> = .010) and barrier recovery (beta = 13.216, <em>P</em> = .001), Black participants also had better dynamic barrier function (beta = −2.956, <em>P</em> = .006) and barrier integrity (beta = 6.794, <em>P</em> &lt; .001), and higher body mass index was associated with better barrier integrity (beta = 0.289, <em>P</em> = .033). Subanalysis of protein expression from tape strips among 20 participants showed that protein families linked to barrier composition and insult response were higher among participants with above-median barrier function and below-median C-reactive protein (<em>P</em> &lt; .01).</div></div>","PeriodicalId":73548,"journal":{"name":"JID innovations : skin science from molecules to population health","volume":"6 4","pages":"Article 100480"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148565612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-throughput, multiplex immunofluorescence for the computer-automated immunophenotyping of Mycosis Fungoides 高通量、多重免疫荧光用于蕈样真菌病的计算机自动免疫分型。
JID innovations : skin science from molecules to population health Pub Date : 2026-07-01 Epub Date: 2026-06-01 DOI: 10.1016/j.xjidi.2026.100494
Patrick McMullan, Marc R. Benoit, Nathan Gasek, Sydney Riddick, Joseph Masison, Katalin Ferenczi, David Rowe, Gillian Weston
{"title":"High-throughput, multiplex immunofluorescence for the computer-automated immunophenotyping of Mycosis Fungoides","authors":"Patrick McMullan,&nbsp;Marc R. Benoit,&nbsp;Nathan Gasek,&nbsp;Sydney Riddick,&nbsp;Joseph Masison,&nbsp;Katalin Ferenczi,&nbsp;David Rowe,&nbsp;Gillian Weston","doi":"10.1016/j.xjidi.2026.100494","DOIUrl":"10.1016/j.xjidi.2026.100494","url":null,"abstract":"<div><div>The diagnosis of mycosis fungoides is difficult and often delayed, exacerbated by the limitation of conventional immunohistochemistry to analyze only 1 antigen per tissue section, often necessitating repeat biopsies and extensive workups. We sought to validate a high-throughput multiplex immunofluorescence method, coupled with computer-automated image analysis, to generate comprehensive immunophenotyping data from a single formalin-fixed, paraffin-embedded biopsy. We applied an 11-biomarker multiplex immunofluorescence panel across 18 archived skin specimens (9 mycosis fungoides/TCR clonality positive and 9 control/TCR clonality negative). Initial validation confirmed that multiplex immunofluorescence antigen expression and spatial localization were concordant with those of sequential immunohistochemistry-stained sections. Whole-slide image stacks were analyzed using both computer-assisted and computer-automated pipelines. Both methods successfully delineated immunophenotypic differences. Mycosis fungoides specimens showed a significant expansion of hematopoietic cells, atypical T-lymphocytes, and proliferative T-lymphocytes when compared with controls. Our results validate the potential of multiplex immunofluorescence to obtain comprehensive, high-dimensional diagnostic information from a single tissue section. Integration with computer-automated analysis offers a scalable, high-throughput platform that can significantly aid in the timely and accurate diagnosis of cutaneous lymphomas.</div></div>","PeriodicalId":73548,"journal":{"name":"JID innovations : skin science from molecules to population health","volume":"6 4","pages":"Article 100494"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13330524/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148392664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书